Home › Products › Oncology › Irnotop 40mg Injection

Irnotop 40mg Injection

Salt Composition: IRINOTECAN

₹591.00₹843.75

Inclusive of all taxes

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Irnotop 40mg Injection belongs to the group of anti-cancer medicines or cytostatics. The active ingredient is Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.

Myelosuppression (bone marrow suppression leading to low levels of RBC, WBC, and platelets in the blood) and diarrhoea are the most common adverse effects of this medication. Other common side effects of Irnotop 40mg Injection include nausea, vomiting, abdominal pain, constipation, anaemia, pain, fatigue, fever, infections including sepsis, abnormal bilirubin levels, hair loss, and weight loss. Inform your doctor if these side effects disturb or persist.

Notify your doctor if you have chronic inflammatory bowel disease or bowel obstruction or if you have taken any live vaccines. Inform your physician if you are allergic to Irnotop 40mg Injection and its ingredients.

Before starting treatment, inform your physician if you have liver problems or jaundice, kidney and heart problems, asthma, high blood pressure or high cholesterol, or severe diarrhoea. If you are smoking or have ever received radiation therapy, report to your healthcare provider. Inform your healthcare provider if you take other medicines, herbs, and supplements.

Effective contraception (birth control) by males and females during treatment is important to avoid pregnancy. Your physician will perform blood tests during and before treatment to check the effects of Irnotop 40mg Injection on blood counts or blood chemistry.

Uses

Treatment of metastatic cancer of the colon and rectum (large intestine).

How it works

Irinotecan works by converting its active metabolite with the help of liver enzymes and inhibits the Topoisomerase I enzyme. This causes damage to the DNA synthesis and its replication, thus preventing the cancer cells from growing and spreading.

How to Use

Take this medicine exactly as prescribed. Your healthcare professional administers it into your vein. Do not self-administer. Your physician will recommend a DNA test before taking this medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Early and late diarrhea Allergic reactions Kidney impairment Lung problems Low levels of RBC, WBC, and platelets in the blood Common Nausea, vomiting, abdominal pain Constipation Diarrhea Anemia Pain Fatigue Fever, infections including sepsis Abnormal bilirubin levels Hair loss Weight loss

Expert Tips

This medicine should be taken cautiously in patients with kidney disease or who have undergone dialysis. Diarrhea is the first sign of Irnotop 40mg Injection. It may be serious if diarrhea starts more than 24 hours after administration of this medication. It should be treated immediately and kept under close supervision. If left untreated, it could lead to dehydration and serious chemical imbalances, which can be life-threatening. Try to avoid laxatives and stool softeners while taking Irnotop 40mg Injection. Drink large amounts of water and rehydration fluids immediately. Take antidiarrheal treatment like loperamide. Notify your doctor if you experience any serious side effects. Contact your doctor for more information. Do not stop the medicine until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose.

References

  1. Accord Healthcare Limited, Electronic Medicines Compendium (EMC), [Revised on June 2022] [Accessed on 1st June 2023], https://www.medicines.org.uk/emc/files/pil.7318.pdf
  2. Pharmacia & Upjohn Co, US Food & Drug Administration, [Revised on Dec 2014] [Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020571s048lbl.pdf
  3. I.D. Penman, C.W. Lees, Alimentary Tract and Pancreatic Disease, Davidson’s Principles and Practice of Medicine, 22nd Edition, 2014, 837-920.
  4. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.

Safety Advice

Pregnancy: unsafe Irnotop 40mg Injection is unsafe during pregnancy as it may harm the developing baby. Women with potential childbearing use effective contraceptives during and after six months after treatment.

Lungs: Consult your doctor It is unknown whether Irnotop 40mg Injection is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

Breastfeeding: unsafe It is unsafe to use during breastfeeding as Irnotop 40mg Injection and its metabolites are found in human milk. It must be discontinued for the duration of therapy. Consult your doctor for advice.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS